Speaking of Science Blog

In biopharma, complexity is inevitable. Scientific innovation, regulatory requirements, and evolving treatment landscapes all contribute to a level of technical depth that is both necessary and, at times, overwhelming. For years, plain language has been treated as a compliance requirement. It has often been seen as a box to check when developing patient materials or […]